Paloma Partners’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-7,007
| Closed | -$200K | – | 2091 |
|
|
2018
Q4 | $200K | Sell |
7,007
-31,595
| -82% | -$898K | 0.01% | 1061 |
|
|
2018
Q3 | $1.08M | Buy |
38,602
+25,585
| +197% | +$720K | 0.02% | 706 |
|
|
2018
Q2 | $363K | Buy |
+13,017
| New | +$349K | 0.01% | 1182 |
|
|
2017
Q3 | – | Sell |
-17,603
| Closed | -$441K | – | 2634 |
|
|
2017
Q2 | $441K | Sell |
17,603
-39,968
| -69% | -$990K | 0.01% | 1618 |
|
|
2017
Q1 | $1.54M | Buy |
+57,571
| New | +$1.59M | 0.02% | 960 |
|
|
2016
Q4 | – | Sell |
-34,877
| Closed | -$871K | – | 2240 |
|
|
2016
Q3 | $871K | Sell |
34,877
-5,438
| -13% | -$127K | 0.01% | 1117 |
|
|
2016
Q2 | $874K | Buy |
+40,315
| New | +$719K | 0.01% | 1239 |
|
|
2015
Q3 | – | Sell |
-10,400
| Closed | -$149K | – | 2110 |
|
|
2015
Q2 | $149K | Sell |
10,400
-3,525
| -25% | -$59.7K | ﹤0.01% | 1629 |
|
|
2015
Q1 | $241K | Buy |
+13,925
| New | +$246K | 0.01% | 1038 |
|
|
2014
Q4 | – | Sell |
-367,400
| Closed | -$4.82M | – | 1476 |
|
|
2014
Q3 | $4.82M | Hold |
367,400
| – | – | 0.22% | 98 |
|
|
2014
Q2 | $5.28M | Sell |
367,400
-177,955
| -33% | -$2.32M | 0.22% | 110 |
|
|
2014
Q1 | $6.95M | Sell |
545,355
-154,645
| -22% | -$2.02M | 0.45% | 48 |
|
|
2013
Q4 | $7M | Buy |
700,000
+350,000
| +100% | +$3.97M | 0.35% | 65 |
|
|
2013
Q3 | $4.61M | Hold |
350,000
| – | – | 0.18% | 94 |
|
|
2013
Q2 | $5M | Buy |
+350,000
| New | +$4.4M | 0.28% | 89 |
|
Other funds holding NXTM
Paloma Partners's NXTM Position: Q1 2019 in Review
Paloma Partners sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 7,007 shares — an estimated $200K sold.
Paloma Partners first reported a position in NXTM in Q2 2013 and held it in 15 quarters. The position peaked at $7M in Q4 2013. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Paloma Partners reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Paloma Partners sold 7,007 NxStage Medical Inc. shares in Q1 2019, an estimated $200K.
- Paloma Partners first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 15 quarters.
- Paloma Partners's NxStage Medical Inc. position peaked at $7M in Q4 2013.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.